Americans Seek Psychedelic 'Reset' in Mexico Amid Rising Costs and Health Risks
Elite CEOs and professionals are paying up to $20,000 for ibogaine treatments abroad, despite warnings of potentially fatal side effects.
Americans are traveling to Mexico and other Latin American countries to undergo ibogaine treatments, with some paying as much as $20,000 for the psychedelic therapy. While marketed for addiction treatment, mental reset, and improved performance, these journeys carry significant and potentially deadly health risks, including cardiac complications.
Ibogaine is not approved for medical use in the United States, leading many to seek treatment abroad. Clinics in Mexico, such as Ibogaine Clinic in Playa del Carmen and Beond Ibogaine in Cancún, facilitate travel logistics, accommodations, and medically supervised care, often combined with wellness activities like yoga and meditation. The New York Post reports that health and optimization clients at Beond typically spend around 10 days at the facility, with costs ranging from $12,500 to $20,000.
The trend has gained renewed attention following the death of Presley Gerber, son of Cindy Crawford, who had spoken publicly about undergoing an ibogaine treatment in Mexico to address addiction and "rewire" his brain. However, addiction specialist Dr. Drew Pinsky cautioned against viewing ibogaine or other psychedelic therapies as a definitive cure for substance-use disorder, stating that there is nothing inherently magical about them.
Beyond addiction, some clinics are promoting ibogaine for personal growth, burnout recovery, and enhanced performance. Mike Stratton, a health company co-founder, described his high-dose ibogaine experience as a "hell ride" that brought forth memories and thoughts, with effects lasting over 24 hours and inducing a dreamlike state. This intensive experience highlights the profound psychological impact of the treatment.
Despite the allure of a mental reset, the risks associated with ibogaine are considerable. The drug can interfere with heart function, posing a risk of fatal cardiac events. This danger is amplified at facilities where medical screening, emergency preparedness, and follow-up care standards can vary widely. The New York Times noted a significant increase in ibogaine clinics in Mexico, from almost none a decade ago to at least 40, with treatment costs ranging from approximately $5,000 to nearly $20,000, excluding travel expenses. These establishments range from luxury operations with medical professionals to more informal settings.